Afatinib/bevacizumabAcquired resistance: 8 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1726卷 / 1期

关键词：

D O I：

10.1007/s40278-018-53659-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：20 / 20

相关论文

共 50 条

[1] Afatinib/osimertinibDrug resistance: 5 case reports
Reactions Weekly, 2019, 1778 (1) : 18 - 18
[2] BevacizumabAcquired drug resistance: case report
Reactions Weekly, 2016, 1602 (1) : 54 - 54
[3] Afatinib/crizotinib/gefitinibDevelopment of resistance: 2 case reports
Reactions Weekly, 2018, 1712 (1) : 34 - 34
[4] Afatinib/gefitinib/osimertinibAcquired resistance: 4 case reports
Reactions Weekly, 2020, 1806 (1) : 21 - 21
[5] Afatinib/gefitinib/osimertinibDrug resistance: 3 case reports
Reactions Weekly, 2019, 1773 (1) : 18 - 18
[6] Afatinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1708 (1) : 28 - 28
[7] Afatinib/erlotinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1696 (1) : 18 - 18
[8] Afatinib/osimertinibAcquired resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1858 (1) : 20 - 20
[9] AntineoplasticsDrug resistance: 8 case reports
Reactions Weekly, 2020, 1807 (1) : 25 - 25
[10] AntineoplasticsDevelopment of resistance: 8 case reports
Reactions Weekly, 2020, 1792 (1) : 29 - 29

← 1 2 3 4 5 →